Reddit Posts
LPCN gets FDA approval - and is beaten down -25% in pre-market. WTF?
[LPCN] FDA approves TLANDO (testosterone undecanoate) oral treatment for testosterone replacement therapy
Anyone playing Lipocine (LPCN) for the FDA approval decision Monday?
How do you guys feel about LPCN’s future?
$LPCN Positive PH3 results - something to checkout if you’re into biotechs
An Illustration of Five Different Bullish Positions at Different Fills
$LPCN some bigwig really doesn’t want this to run. Hate this manipulation smh
Looking for a bear opinion on $LPCN
Anyone notice how most of the top DD posted on here this year, came around the peak of the stock and the stock has only fallen since?
LPCN & QTNT: Two HIGH RISK Penny Stocks With Better than Average Potential
Mentions
I can give you other pharma stocks at the bottom; GNPX, LPCN
LPCN, worth looking into as a long term play, just an undervalued phase 2 pharma
!BanBet LPCN to hit over 5.50 by June
$LPCN...Epic squeeze incoming...shorts dog piling...low float and positive Phase 2 data release...
LPCN, I think there topline data readout from their phase 2 liver cirrhosis therapy trial comes out tomorrow (They've said by the end of the quarter). Historically they've had a spike and then sell the news on their catalysts.
Let's make America great again LOL, LPCN to the moooooon!! 😁🇺🇸😎 AMC and GME still a win. Good luck friends 💙
💰💰💰Get new daily runners and watchlist in our app! #premarket #watchlist 07/27 $MNK - old news+big volume(+50%), $CTCX - Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (+50%) $LPCN - Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis (+36%), $CLS - Earnings (+28%) https://preview.redd.it/zqyo5fxy4ieb1.jpeg?width=576&format=pjpg&auto=webp&s=da9e1db525c280c7b57a1de7912be50e24104203
💰💰💰Get new daily runners and watchlist in our app! #premarket #watchlist 07/27 $MNK - old news+big volume(+50%), $CTCX - Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (+50%) $LPCN - Phase 2 Study Meets Primary Endpoint in Patients with Cirrhosis (+36%), $CLS - Earnings (+28%) https://preview.redd.it/qr4jg41w4ieb1.jpeg?width=576&format=pjpg&auto=webp&s=2055ccfeabc5832d4f6c565374e0953f5b953579
Thoughts for LPCN over the weekend? I bought at .53
LPCN - Small bio-tech with great financials, income from already release products, and others in the pipeline. Lots of room for growth!
Hey /u/38931841Hz - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: BOXL LPCN RKDA AQB OGEN FTFT EVGN JVA EKSO SFT. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
To be fair my small cap bio position in LPCN is up 8% today
$LPCN is shown at +23% pre-market (after taking a -11% hit yesterday, on earnings which were not great). I wonder if it's just a pre-market artifact or if it will last (can't find any news justifying this bump)
LPCN 4.32% US ER 7.55%.CL SK 3.54% By very green I meant very little red .
LPCN 4.32% US ER 7.55%.CL SK 3.54% By very green I meant very little red .
I’ve been holding a few shares. I bought at 1.22 and sold at 2.15 but then got back in at .83. I also hold LPCN which also has a testosterone pill approved.
LPCN I’m not giving up hope yet!
Take a look at LPCN, AIM, and a few others that tanked after positive reports/FDA updates. You have to fight the bears and shorts by staying long.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LPCN. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
Buying up some LPCN. It’s a steal at these prices.
IONQ + NVTS + RDW + LPCN + NILE . Red almost 3%
Not OP but I have my eye on LIAN, ACER, AKBA. I just got some LPCN which should do well once the deal with ATRS is official.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LPCN LPCN. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LPCN. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LPCN. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: LPCN. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
LPCN: U.S. Food and Drug Administration ("FDA") has approved TLANDO™ (testosterone undecanoate), an oral treatment for testosterone replacement therapy ("TRT") in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. Lipocine licensed the exclusive U.S. commercialization rights for TLANDO™ to Antares Pharma.
why is Lipocine $LPCN down now?
$LPCN Tlando tentative approval (yesterday): https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208088Orig1s000TA_ltr.pdf
Bought LPCN + BGRY Added to CLSK
Two moves you might want to keep on your radar that have great potential: 1. $LPCN - LPCN new drug application for Tlando, an oral prodrug of testosterone containing testosterone undecanoate, on Monday, March 28. Tlando has received tentative approval from the FDA in December for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. 2. $AKBA - AKBA has a PDUFA date of Tuesday, March 29 for its NDA of vadadustat for treating anemia in chronic kidney disease patients. $LPCN already has a partner set up and is close relationship with the FDA for fast tracking other drugs. Don’t see how this first drug isn’t approved seeing as the FDA already granted tentative approval. $AKBA is what long term investors of the stock were waiting for since July of 2021. FDA approval looks likely but can’t say. $LPCN is a lot safer if a bet.
Two moves you might want to keep on your radar that have great potential: 1. $LPCN - LPCN new drug application for Tlando, an oral prodrug of testosterone containing testosterone undecanoate, on Monday, March 28. Tlando has received tentative approval from the FDA in December for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism. 2. $AKBA - AKBA has a PDUFA date of Tuesday, March 29 for its NDA of vadadustat for treating anemia in chronic kidney disease patients. $LPCN already has a partner set up and is close relationship with the FDA for fast tracking other drugs. Don’t see how this first drug isn’t approved seeing as the FDA already granted tentative approval. $AKBA is what long term investors of the stock were waiting for since July of 2021. FDA approval looks likely but can’t say. $LPCN is a lot safer if a bet.
[LPCN await FDA approval](https://www.billionaireclubcollc.com/the-week-ahead-in-biotech-march-27-april-2-lipocine-akebia-merck-await-fda-verdicts-adcom-test-for-amylyx-biontech-earnings-and-more/)
Thinking of getting some LPCN.
Time to go balls deep on something balls related. LPCN (Lipocene) and ATRS (Antares Pharma) FDA approval decision due on Monday for their New Drug Application (NDA), but it has already been approved. Seems like a no brainer. Think with your balls guys. >FDA decision on TLANDO as oral testosterone replacement therapy in adult males for conditions associated with hypogonadism. >FDA granted tentative approval for Tlando on Dec.8, 2020 >Lipocine licensed the exclusive U.S. rights for TLANDO to Antares Pharma in Oct.2021 Tentative approval >"(also known as “TA”) is a notification granted by the FDA if an ANDA meets the substantive requirements for approval, but cannot obtain final approval for marketing due to unexpired patents or exclusivities. From the Lipocene 10-K filing: >TLANDO has not received final approval and is not eligible for final approval to market in the U.S. until the expiration of the exclusivity period previously granted to Clarus Therapeutics, Inc. (“Clarus”) with respect to JATENZO®, which expires on March 27, 2022. The FDA has affirmed to Antares the acceptance of the resubmission of the NDA for TLANDO filed on January 28, 2022. The FDA has designated the NDA as a Class 1 resubmission with a two-month review goal period and set a target action date of March 28, 2022 under the Prescription Drug User Fee Act (PDUFA). So hoping Monday for a quick earner on the news. Hope to see either or both on the Finviz homepage Monday open. Heavily weighted towards LPCN since they seem to be the ones making all the licensing money, and $1.85 right now. ATRS is about $4.06. There has been some upward momentum of late, so guessing a lot of people have been filling their boots awaiting Monday.
LPCN Need to get in before market open.
Time to go balls deep on something balls related. LPCN (Lipocene) and ATRS (Antares Phama) FDA approval decision due on Monday, but it has already been approved. Seems like a no brainer. Think with your balls guys. >FDA decision on TLANDO as oral testosterone replacement therapy in adult males for conditions associated with hypogonadism. >FDA granted tentative approval for Tlando on Dec.8, 2020 >Lipocine licensed the exclusive U.S. rights for TLANDO to Antares Pharma in Oct.2021 Tentative approval >"(also known as “TA”) is a notification granted by the FDA if an ANDA meets the substantive requirements for approval, but cannot obtain final approval for marketing due to unexpired patents or exclusivities. So hoping Monday for a quick earner on the news. Hope to see either or both on the Finviz homepage Monday open. Heavily weighted towards LPCN since they seem to be the ones making all the licensing money.
LPCN I bought it a few months ago to practice selling covered calls. I bought at like $1.22 or something and sold enough $1.50 calls that always expired worthless to get my cost basis down to $0.99. But for some reason the calls for March were only for $2.50, $5, or $7 and no one was buying them, so I was just sitting in the shares. And all of a sudden this past week or two the price has been climbing, currently at $1.85, and people are talking like it may go to $3 or even $6 after they get some FDA approval next week. Been wild. lol
Going half balls deep on ATRS and LPCN. FDA approval decision due on Monday. >FDA decision on TLANDO as oral testosterone replacement therapy in adult males for conditions associated with hypogonadism. Just looking for a lottery ticket.
 LPCN breakout soon. Lipocine currently priced at $1.80 a share. A month and a half ago was at $0.89. Has FDA approval for TLANDO March 28th as catalyst 1 and then NASH news as catalyst two with direct access to fast tracking with the FDA. It is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. TLANDO has gotten tentative FDA approval back in December of 2020. The reason why it is tentative is because a Company named Clarus had a patent on the same type of drug so the FDA said they cannot sell until Clarus’ patent expired which is March 28th. LPCN has 4 other drugs that are in the pipeline that have yielded great results another form of TLANDO, NASH and are on the ending phases sometime in June. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth ALOT of good going on with this company and in my opinion very undervalued. Zach’s PT has it at $10.00 with a strong buy rating HC wraithwright has it at a buy at $3.00 Landenburg Thalm has it at a buy at $3.00 Check it out [LPCN research and rating](https://www.zacks.com/stock/research/LPCN/stock-style-scores) US PATENT APPROVED APRIL 12 2021 PATEL HAS ANNOUNCED A PARTNERSHIP WITH ANTRES. This company has very low debt as well and a lot of cash and revenue to keep it going.
LPCN been steady climbing throughout all these swings snd volatility. Unphased just walking up a staircase.
LPCN has been rallying lately. Might be a good swing play
Bought into LPCN at very cheap eyeing this day for FDA approval. Really love the potential growth of hormone therapy especially for men with low t levels as they age. I think it’s a potential boom industry and I’m really interested in it so I made moves to invest in it and watching it go up some is great.
$LPCN is supposed to have a catalyst on Friday but who knows... (what, am I rattled by these last few days? noooo)
Want super high risk, high reward? LPCN and CBDD.
Most likely to succeed: NAKD Maybe: LPCN Maybe: SESN
Failed January trade. LPCN is down 40% since the big January DD that got everyone hooked. https://www.reddit.com/r/pennystocks/comments/l0lbo2/in\_depth\_lpcn\_dd\_next\_catalyst\_huge\_upside/
LPCN I bought a nice amount at $1.10 it spiked up and then came back down. It's products are developed to help people with various degrees of lowered hormones. They have a treatment that could prolong life with people with liver issues. One of there products have been FastTracked by the FDA, not some guy pumping a stock on YouTube... Yes the Federal Drug Administration, has fastracked; LPCN 1144 An oral prodrug of bioidentical testosterone being developed for pre-cirrhotic NASH. ***Check out there website: https://www.lipocine.com/ My strategy using some of my profits from ILUS and putting into LPCN. Once a drug receives Fast Track designation, early and frequent communication between the FDA and a drug company is encouraged throughout the entire drug development and review process. The frequency of communication assures that questions and issues are resolved quickly, often leading to earlier drug approval and access by patients.
$LPCN just got a $6 price target from Zacks but they haven’t dropped PR on it yet. That’s 600% from the current price. Go get it before the PR wire hits
I have LPCN, I don't know why, but it has calls so that's fun!
Only one of these I am in is LPCN. I like the company, they have around 40 million in cash on hand and burn through about 3-4 mil a quarter so I dont foresee an offering very soon to torpedo the price. They do have options so you can sell CC's to get decent premiums. They have stuff in the pipeline as evidenced by the patent news today. Pretty low risk in my opinion.
$LPCN Zacks is going to drop a report soon. Their analyst responded to a Twitter comment after partnership news dropped. They’re working in an updated report and like the partnership. Last time this happened was March and it went vertical with 20x normal volume
$LPCN Partnership news!!! Finally dropped.
I used your filters and got a handful of stocks , also the LPCN you mentioned above. But all these stocks have a SELL rating. If they're oversold, shouldn't they rather have a BUY rating?
A few I have on watch right now are $FNHC $LPCN $FTFT and $PBTS
$LPCN biopsy results for NASH coming out this month.
LPCN. Data for NASH expected any day now. Potential for 10-20x run if that’s tight. Downside is actually pretty minimal of you’re willing to hold 18months for their other drug to start commercial lunch when competitor exclusivity expires. Would make the Loss from Possible NASH failure disappear at a minimum.
Thanks for the game homie! 💪🏼Word on the street this is gonna fly monday 👀 I think the plays are 8/20 XSPA IGC calls and 1/21 LPCN calls 👍🏼
LPCN, huh? Made a tidy profit off of them about a year ago, but had no idea they were back and relevant. Any major catalysts coming upV
The table shows a breakdown of percentage of call options bought/sold versus the percentage of put options bought/sold. For LPCN, on Friday 100% of the options volume were call options.
I missed this one - FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study. https://finance.yahoo.com/news/fda-clears-lpcn-1154-ind-120000303.html
I missed this one - FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study. https://finance.yahoo.com/news/fda-clears-lpcn-1154-ind-120000303.html
LPCN is just a zombie company. They do just barely enough to stay afloat.
LPCN now has at least three analyst buy ratings with a price target between $2.50 and $10.
LPCN has potential for August due to LPCN 1144
Anyone else looking at LPCN? Cantor Fitzgerald initiated on 6/23/21 with a price target of $3 (currently at $1.40 after a price drop due to a summary judgment against them in their lawsuit against Clarius Therapeutics for patent infringement). However, LPCN has a nice catalyst coming up in August 2021: LPCN 1144: Tx for Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH). “Phase 2 top-line change in liver fat data met primary endpoint January 12, 2021. 36-week biopsy data are expected August 2021.” LPCN beat expected EPS for Q1 21. Next earnings date is 8/5 premarket. Two big IFs: IF they perform as expected or outperform on earnings in August and IF the 36 week biopsy data in August is positive, it should print. Calls are currently cheap: 8/20/21 1.5c $0.15. 8/20/21 2.0c $0.13. Not financial advice, DYOR, etc.
Trying to hit a 2x profit on a trade. Organized from most risk to least. Here’s a few plays I have been thinking. 1. Buy Tesla OTM weeklies on Friday before earning. 2. By OTM weeklies on AMD the day INTC earning happens last time theses went up 3X. ( AMD OTM weeklies are cheap on INTC earning because IV is usually low but if INTC does bad it means AMD is taking away market share. if INTC does well it just means that specific growth sector is doing well. If no price movement I’ll just sell the following day. * special double play: INTC puts week of earning ( made 150% last time on put spread). 3. CLOV OTM but 1-2 months out. 4. Go and buy DBVT stock and hold for a year 5. Buy LPCN stock and hold 6. Buy GSAT stock and wait until Starlink goes public and the entire sector experiences growth.
Been a while since I've come through. New tickers I've got contracts on this week: $GCI, $LPCN, $WISH (FDs), $SRNG, $GSAT, $BP, $BAC
The only other company I believe that is playing with oral testosterone replacement is LPCN This is a game changer in the testosterone replacement world
Thinking the IQ & VIVO dips look nice. LPCN is my favorite penny Shit ton of news to trade on as the markets open on Monday though. . https://moongangcapital.com/2021/04/24/04-26-2021-pre-market-brief-weekend-edition/
Thinking the IQ & VIVO dips look nice. LPCN is my favorite penny Shit ton of news to trade on as the markets open on Monday though. https://moongangcapital.com/2021/04/24/04-26-2021-pre-market-brief-weekend-edition/
Thinking the IQ & VIVO dips look nice. LPCN is my favorite penny. Shit ton of news to trade on as the markets open on Monday though. https://moongangcapital.com/2021/04/24/04-26-2021-pre-market-brief-weekend-edition/
On /r/pennystocks, /u/carshopper123 has previously mentioned: |||| |:-|:-|:- **ticker**|LPCN|NASH **mentions**|2|1 /u/carshopper123's account was created **11 months ago**. It has **224** comment karma and **27** link karma. ----- ^You ^may ^see ^tickers ^you ^didn't ^mention ^-- ^I'm ^casting ^a ^wide ^net ^because ^y'all ^don't ^always ^$TAG ^your ^ticker ^symbols. ^This ^was ^an ^automated ^response. ^If ^you ^have ^feedback, ^please ^reply ^to ^this ^comment ^or [^(send me a message)](https://www.reddit.com/message/compose?to=RichSteps&subject=bot%20feedback)^.
Sticking with $LPCN. Too much potential to ignore.
Hanging out in LPCN (covered calls monthlies) and IQ. Overnight news: Housing data released today, NFLX tanks on lower than expected subscriber increases, and AAPL targeted on ransom ware attack. https://moongangcapital.com/2021/04/21/04-21-2021-pre-market-brief-news-while-the-market-was-closed/
Hanging out in LPCN (covered calls monthlies) and IQ. Overnight news: Looks like BA actually sold some planes 🤣. China hates TSLA. And BBBY insider buying. https://moongangcapital.com/2021/04/20/04-20-2021-pre-market-brief-news-while-the-market-was-closed/